PET a neuroonkológiában--indikációk, elkülönító diagnózis és klinikai alkalmazás.

Translated title of the contribution: The PET scan in neuro-oncology--indications, differential diagnosis and clinical application

László Novák, M. Emri, L. Balkay, L. Galuska, O. Ésik, P. Molnár, György Csécsei, L. Trón

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Results of 157 PET (positron emission tomography) studies in 102 patients with known or presumed intracranial (ic.) tumors are reviewed. In 106 studies [18F]-2-fluoro-2-deoxy-D-glucose (FDG) and in 51 cases [11C]-methionine (MET) was used as the PET tracer. CT and MRI imaging accompanied the PET studies in each case. Results of pre- and/or postoperative studies are compared. PET was concluded to have a fundamental role in the precise differential diagnosis in case of ic. space-occupying pathologies since it is capable of providing information that is not obtainable or may be equivocal based solely on CT and/or MRI investigations. However, it is also mandatory to be aware of the limits of PET.

Original languageHungarian
Pages (from-to)1289-1294
Number of pages6
JournalOrvosi Hetilap
Volume143
Issue number21 Suppl 3
Publication statusPublished - May 26 2002

Fingerprint

Positron-Emission Tomography
Differential Diagnosis
Fluorodeoxyglucose F18
Methionine
Pathology
Neoplasms

ASJC Scopus subject areas

  • Medicine(all)

Cite this

PET a neuroonkológiában--indikációk, elkülönító diagnózis és klinikai alkalmazás. / Novák, László; Emri, M.; Balkay, L.; Galuska, L.; Ésik, O.; Molnár, P.; Csécsei, György; Trón, L.

In: Orvosi Hetilap, Vol. 143, No. 21 Suppl 3, 26.05.2002, p. 1289-1294.

Research output: Contribution to journalArticle

@article{ae0caeba05a84d819bea8f8705a25276,
title = "PET a neuroonkol{\'o}gi{\'a}ban--indik{\'a}ci{\'o}k, elk{\"u}l{\"o}n{\'i}t{\'o} diagn{\'o}zis {\'e}s klinikai alkalmaz{\'a}s.",
abstract = "Results of 157 PET (positron emission tomography) studies in 102 patients with known or presumed intracranial (ic.) tumors are reviewed. In 106 studies [18F]-2-fluoro-2-deoxy-D-glucose (FDG) and in 51 cases [11C]-methionine (MET) was used as the PET tracer. CT and MRI imaging accompanied the PET studies in each case. Results of pre- and/or postoperative studies are compared. PET was concluded to have a fundamental role in the precise differential diagnosis in case of ic. space-occupying pathologies since it is capable of providing information that is not obtainable or may be equivocal based solely on CT and/or MRI investigations. However, it is also mandatory to be aware of the limits of PET.",
author = "L{\'a}szl{\'o} Nov{\'a}k and M. Emri and L. Balkay and L. Galuska and O. {\'E}sik and P. Moln{\'a}r and Gy{\"o}rgy Cs{\'e}csei and L. Tr{\'o}n",
year = "2002",
month = "5",
day = "26",
language = "Hungarian",
volume = "143",
pages = "1289--1294",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "21 Suppl 3",

}

TY - JOUR

T1 - PET a neuroonkológiában--indikációk, elkülönító diagnózis és klinikai alkalmazás.

AU - Novák, László

AU - Emri, M.

AU - Balkay, L.

AU - Galuska, L.

AU - Ésik, O.

AU - Molnár, P.

AU - Csécsei, György

AU - Trón, L.

PY - 2002/5/26

Y1 - 2002/5/26

N2 - Results of 157 PET (positron emission tomography) studies in 102 patients with known or presumed intracranial (ic.) tumors are reviewed. In 106 studies [18F]-2-fluoro-2-deoxy-D-glucose (FDG) and in 51 cases [11C]-methionine (MET) was used as the PET tracer. CT and MRI imaging accompanied the PET studies in each case. Results of pre- and/or postoperative studies are compared. PET was concluded to have a fundamental role in the precise differential diagnosis in case of ic. space-occupying pathologies since it is capable of providing information that is not obtainable or may be equivocal based solely on CT and/or MRI investigations. However, it is also mandatory to be aware of the limits of PET.

AB - Results of 157 PET (positron emission tomography) studies in 102 patients with known or presumed intracranial (ic.) tumors are reviewed. In 106 studies [18F]-2-fluoro-2-deoxy-D-glucose (FDG) and in 51 cases [11C]-methionine (MET) was used as the PET tracer. CT and MRI imaging accompanied the PET studies in each case. Results of pre- and/or postoperative studies are compared. PET was concluded to have a fundamental role in the precise differential diagnosis in case of ic. space-occupying pathologies since it is capable of providing information that is not obtainable or may be equivocal based solely on CT and/or MRI investigations. However, it is also mandatory to be aware of the limits of PET.

UR - http://www.scopus.com/inward/record.url?scp=0037177973&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037177973&partnerID=8YFLogxK

M3 - Article

C2 - 12077919

AN - SCOPUS:0037177973

VL - 143

SP - 1289

EP - 1294

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 21 Suppl 3

ER -